News

2019 News

Vancouver BC / NEWSWIRE / May 1, 2019 /CNW/ - Agrios Global Holdings Ltd. (CSE: AGRO) (OTCQB: AGGHF) (FSE: ØSA - WKN-A2N62K) ("Agrios" or the "Company") is pleased to announce that it has retained GBC AG (“GBC”), to provide independent research coverage  for the Company.  

Based in Augsburg, GBC is one of the leading independent research and investment companies in the European financial community. GBC provides independent corporate analysis and research for SME’s involved in both the capital markets and private sector. GBC Kapital GmbH, a subsidiary, provides corporate finance solutions and capital market advisory services for private placements, financings and brokerage of stock and bonds.

Since 2001, GBC has held extremely popular, invitation only, capital market conferences as well as providing investment research and capital markets advisory services. The GBC conferences offer an optimal information and network platform for communication between analyst monitored companies and institutional investors, portfolio managers, asset managers and family offices.  International participants present their business models, outlook for current and future projects and the progress of their business development at these well attended events. In addition, conference attendees are able to book 1-on-1 meetings with the presenting companies.

GBC’s Münchner Kapitalmarkt Konferenz (MKK), which is held twice annually, is now the largest capital market conference in Southern Germany. Herrick Lau, CFO of Agrios stated, “Companies that are monitored by analysts usually come and remain in the focus of institutional investors more readily. We are looking forward to engaging with participants at GBC’s upcoming events.”

Manuel M. Hoelzle, Head of Research at GBC AG stated “We are pleased to initiate coverage on Agrios Global Holdings. Our analysts are strongly convinced of the future potential of cannabis in the medical sector in the US, but we also see a high market potential for Agrios in Europe, and especially Germany. In our opinion Agrios uses a very interesting technological approach that could create a competitive edge.”

GBC will receive a 45,900 € retainer for its portfolio of services, effective May 1, 2019.

About Agrios Global Holdings Ltd.

Agrios Global Holdings is a data analytics driven agriculture technology and services company advancing the latest innovations in indoor growing science. The Company owns, leases and manages properties and equipment for eco-sustainable agronomy and provides advisory services to support all aspects of aeroponic cultivation in the cannabis sector. Agrios is actively pursuing new opportunities to expand its portfolio of tenant growers and infrastructure assets in strategic licensed jurisdictions. Based in Vancouver, BC. Agrios is managed by a highly accomplished team of experienced industry and capital markets experts who are committed to the growth of the company.

For further information please contact:

Ute Koessler
T: 604-336-2444
investor@agriosglobal.com

This news release was prepared by management of Agrios, which takes full responsibility for its contents. The Canadian Securities Exchange ("CSE") has not reviewed and does not accept responsibility for the adequacy of this news release.  Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Agrios' periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to corporate strategy and Agrios’ ability to execute such strategy, future developments regarding Agrios’ expansion into various markets including numerous states within the United States of America, and into Asia, expected costs of hemp fiber, intended development and sales of hemp products, market demand for hemp products, and the business and operations of Agrios as it relates to the Yunnan Province

Although Agrios has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Agrios disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Agrios does not assume any liability for disclosure relating to any other company mentioned herein.

###

Subscribe for email updates